Overview

SBRT or TACE for Advanced HCC

Status:
Recruiting

Trial end date:
2022-12-31

Target enrollment:

Participant gender:

Summary

Randomized study of stereotactic body radiation therapyRANDOMIZED STUDY OF STER (SBRT) versus transarterial chemoembolization (TACE) in locally advanced hepatocellular carcinoma.

Phase:

Phase 3

Details

Lead Sponsor:

University of Aarhus

Collaborator:

International Atomic Energy Agency

Treatments:

Doxorubicin